Literature DB >> 12089251

Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA.

Jason L Sanchez1, Gregory A Storch.   

Abstract

We created a multiplex, quantitative, real-time PCR assay that amplifies cytomegalovirus (CMV) and human DNA in the same reaction tube, allowing for a viral load determination that is normalized to measured human DNA. The assay targets a conserved region of the CMV DNA polymerase gene that is not affected by known drug resistance mutations. All 36 strains of CMV detected by culture or qualitative PCR in a population of lung transplant recipients were detected. The assay detected 1 to 10 copies of CMV plasmid DNA. The analytic sensitivity was not affected by the presence of DNA from 10(6) human cells but was reduced approximately 10-fold by alkaline lysates of leukocyte preparations. CMV quantitation was linear over a range of 10(1) to 10(6) copies. The intraassay and interassay coefficients of variation were 29 and 40%. Human DNA was regularly detected in patient plasma samples, and the amount was increased by storage of blood at room temperature before plasma separation and by plasma separation techniques that allowed leukocyte contamination. Applied to whole blood, the assay provides a measurement of CMV DNA in relation to cellular content without a need for cell counting procedures. Applied to plasma, the assay can reveal artifactual increases in plasma CMV levels resulting from leukocyte contamination. Further study of the utility of this assay to monitor patient populations at risk for CMV disease is warranted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089251      PMCID: PMC120584          DOI: 10.1128/JCM.40.7.2381-2386.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

Review 1.  Quantitative aspects of plasma/serum DNA in cancer patients.

Authors:  P Anker
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 2.  Prevention of cytomegalovirus disease in recipients of solid-organ transplants.

Authors:  C V Paya
Journal:  Clin Infect Dis       Date:  2001-02-06       Impact factor: 9.079

3.  Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories.

Authors:  S Chou; N S Lurain; A Weinberg; G Y Cai; P L Sharma; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

4.  Use of two reporter dyes without interference in a single-tube rapid-cycle PCR: alpha(1)-antitrypsin genotyping by multiplex real-time fluorescence PCR with the LightCycler.

Authors:  N von Ahsen; M Oellerich; E Schütz
Journal:  Clin Chem       Date:  2000-02       Impact factor: 8.327

5.  Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation.

Authors:  G Boivin; R Bélanger; R Delage; C Béliveau; C Demers; N Goyette; J Roy
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA.

Authors:  A Nitsche; N Steuer; C A Schmidt; O Landt; W Siegert
Journal:  Clin Chem       Date:  1999-11       Impact factor: 8.327

7.  Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants.

Authors:  W Preiser; S Bräuninger; R Schwerdtfeger; U Ayliffe; J A Garson; N S Brink; S Franck; H W Doerr; H F Rabenau
Journal:  J Clin Virol       Date:  2001-01       Impact factor: 3.168

8.  Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.

Authors:  G Gerna; F Baldanti; D Lilleri; M Parea; E Alessandrino; A Pagani; F Locatelli; J Middeldorp; M G Revello
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

9.  False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation.

Authors:  P Schäfer; W Tenschert; M Schröter; K Gutensohn; R Laufs
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 10.  Betaherpesviruses in transplant recipients.

Authors:  P D Griffiths; D A Clark; V C Emery
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

View more
  28 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir.

Authors:  J Trevillyan; P Angus; E Shelton; J Whitlam; F Ierino; J Pavlovic; D Gregory; K Urbancic; J Torresi; A Testro; M L Grayson
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

3.  Criteria for reducing unnecessary testing for herpes simplex virus, varicella-zoster virus, cytomegalovirus, and enterovirus in cerebrospinal fluid samples from adults.

Authors:  Craig B Wilen; Cynthia L Monaco; Joan Hoppe-Bauer; Ronald Jackups; Robert C Bucelli; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

4.  Diagnosis of human congenital cytomegalovirus infection by amplification of viral DNA from dried blood spots on perinatal cards.

Authors:  Lori Scanga; Shu Chaing; Cynthia Powell; Arthur S Aylsworth; Lizzie J Harrell; Nancy G Henshaw; Chris J Civalier; Leigh B Thorne; Karen Weck; Jessica Booker; Margaret L Gulley
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

5.  Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods.

Authors:  Jing Chen; Huidi Zhang; Peirong Chen; Qiaoai Lin; Xiaochun Zhu; Lifang Zhang; Xiangyang Xue
Journal:  Clin Rheumatol       Date:  2015-03-10       Impact factor: 2.980

6.  Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.

Authors:  Sophie Voruz; Peter Gowland; Claudia Eyer; Nadja Widmer; Mélanie Abonnenc; Michel Prudent; Stavroula Masouridi-Levrat; Michel A Duchosal; Christoph Niederhauser
Journal:  Blood Transfus       Date:  2020-02-28       Impact factor: 3.443

7.  Tissue polymerase chain reaction for the diagnosis of cytomegalovirus disease after allogeneic hematopoietic cell transplantation.

Authors:  Armin Rashidi; Kiran R Vij; Richard S Buller; Kristine M Wylie; Gregory A Storch; John F DiPersio
Journal:  Am J Hematol       Date:  2017-02       Impact factor: 10.047

8.  Reactivation Viremia in Pediatric Sepsis.

Authors:  Moonjoo Han; Anna L Roberts; Brooke A Migliore; Ana María Cárdenas; Scott L Weiss
Journal:  Pediatr Crit Care Med       Date:  2020-04       Impact factor: 3.624

9.  Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.

Authors:  William T Seaman; Elizabeth Andrews; Marion Couch; Erna M Kojic; Susan Cu-Uvin; Joel Palefsky; Allison M Deal; Jennifer Webster-Cyriaque
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

10.  Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.

Authors:  Hélène C Laude; Barbara Jonchère; Eve Maubec; Agnès Carlotti; Eduardo Marinho; Benoit Couturaud; Martine Peter; Xavier Sastre-Garau; Marie-Françoise Avril; Nicolas Dupin; Flore Rozenberg
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.